Griet Vanpoucke

Director

Dr. Griet Vanpoucke (PhD) is Head New Ventures at VIB. With her team she translates exciting science from the research institute into successful novel ventures. She currently also serves as non-exec Director on the Board of Orionis Biosciences. Previously she was part of Pronota, a biomarker discovery and diagnostics start-up company. As Director R&D she was responsible for several internal and partnered biomarker discovery programs. She played a leading role in the company’s transformation from a proteomics discovery company to a diagnostic product company until the company was acquired in 2014.

Dr. Vanpoucke holds a PhD in Biotechnology from Ghent University and did a postdoc at the MRC in Edinburgh, UK.